Concepedia

Charles M. Beasley

CM

Statistics

Publications

81

Citations

8.9K

H-Index

48

Active since

1987

Affiliations

Eli Lilly (United States)(Current)

University of Pennsylvania

Massachusetts General Hospital

Harvard University Press

Rush University Medical Center

Charles M. Beasley is an author at Eli Lilly (United States) specializing in psychopharmacology, pharmacotherapy, and psychiatry.

ORCID

Publications per year

1987–2025

81

Publications

81

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

Gary D. Tollefson, Charles M. Beasley, P.V. Tran et al. · American Journal of Psychiatry · 1997 · 901 citations

, , +17

Olanzapine versus Placebo and Haloperidol

Charles M. Beasley, Gary D. Tollefson, P. Tran et al. · Neuropsychopharmacology · 1996 · 787 citations

, , +12

Double-Blind Comparison of Olanzapine Versus Risperidone in the Treatment of Schizophrenia and Other Psychotic Disorders

Pierre V. Trân, S.H. Hamilton, Amy J. Kuntz et al. · Journal of Clinical Psychopharmacology · 1997 · 718 citations

, , +15

Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial

Charles M. Beasley, T.M. Sanger, W. Satterlee et al. · Psychopharmacology · 1996 · 404 citations

, , +11

Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol

G.D. Tollefson, Charles M. Beasley, R. Tamura et al. · American Journal of Psychiatry · 1997 · 284 citations

, , +16

1–5 of 81